Suppr超能文献

中脑导水管周围灰质中5-HT2A和5-HT2C(而非5HT1A)受体在小鼠高架十字迷宫重测范式中的作用。

Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.

作者信息

Gomes K S, Nunes-De-Souza R L

机构信息

Programa de Pós-Graduação em Psicobiologia, FFCLRP-Campus USP, Ribeirão Preto, SP 14040-901, Brazil.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1261-9. doi: 10.1016/j.pnpbp.2009.07.015. Epub 2009 Jul 19.

Abstract

A single exposure to the elevated plus-maze test (EPM) increases open arms avoidance and reduces or abolishes the anxiolytic-like effect of benzodiazepines assessed during a second trial, a phenomenon defined as "one-trial tolerance" (OTT). It has been emphasized that the dorsal portion of the midbrain periaqueductal gray (dPAG) plays a role on this enhanced aversion phenomenon in maze-experienced rodents. Given that intra-dPAG injections of a wide range of serotonergic 5-HT(1A), 5-HT(2A) and 5-HT(2C) receptor agonists produce anxiolytic-like effects in maze-naïve rodents, the present study examined the effects of the 5-HT(1A) receptor agonist 8-OH-DPAT (5.6 and 10.0nmol in 0.15microl) the preferential 5-HT(2A) receptor agonist DOI (2.0 and 8.0nmol in 0.1microl) and the preferential 5-HT(2C) receptor agonist MK-212 (21.2 and 63.6nmol in 0.1microl) microinjected into the dPAG prior to Trial 1 and Trial 2 on the behaviour of mice in the EPM. Test sessions were recorded and subsequently scored for anxiety-like behaviour (percentage of open arms entries and time) as well as general locomotor activity (closed arm entries). The results showed a lack of 8-OH-DPAT (5.6 and 10.0nmol) effect on the behaviour of maze-naïve and maze-experienced mice, while intra-dPAG microinfusions of DOI (8nmol) reduced anxiety-like behaviour only in maze-experienced mice that had received a similar treatment prior to Trial 1. Furthermore, intra-dPAG MK-212 (63.6nmol) showed an anxiolytic-like effect on both Trial 1 and Trial 2. Importantly, these effects were observed in the absence of any significant change in closed arm entries, the parameter considered to be a valid index of locomotor activity in the plus-maze. These results support the dPAG as a crucial structure involved in the neurobiology of the OTT phenomenon as well as accounting the role of the 5-HT(2A) and 5-HT(2C) receptors located within this midbrain structure on the emotional state induced by EPM test and retest paradigm mice.

摘要

单次暴露于高架十字迷宫试验(EPM)会增加对开放臂的回避,并降低或消除在第二次试验中评估的苯二氮䓬类药物的抗焦虑样作用,这一现象被定义为“单次试验耐受”(OTT)。已经强调,中脑导水管周围灰质的背侧部分(dPAG)在迷宫经验丰富的啮齿动物的这种增强的厌恶现象中起作用。鉴于向dPAG内注射多种血清素能5-HT(1A)、5-HT(2A)和5-HT(2C)受体激动剂会在未接触迷宫的啮齿动物中产生抗焦虑样作用,本研究考察了在试验1和试验2之前向dPAG内微量注射5-HT(1A)受体激动剂8-OH-DPAT(0.15微升中含5.6和10.0纳摩尔)、优先5-HT(2A)受体激动剂DOI(0.1微升中含2.0和8.0纳摩尔)和优先5-HT(2C)受体激动剂MK-212(0.1微升中含21.2和63.6纳摩尔)对小鼠在EPM中的行为所产生的影响。记录测试过程,随后对焦虑样行为(开放臂进入百分比和时间)以及一般运动活动(封闭臂进入次数)进行评分。结果显示,8-OH-DPAT(5.6和10.0纳摩尔)对未接触迷宫和有迷宫经验的小鼠的行为均无影响,而向dPAG内微量注射DOI(8纳摩尔)仅在试验1之前接受过类似处理的有迷宫经验的小鼠中降低了焦虑样行为。此外,向dPAG内注射MK-212(63.6纳摩尔)在试验1和试验2中均显示出抗焦虑样作用。重要的是,在封闭臂进入次数没有任何显著变化的情况下观察到了这些效应,封闭臂进入次数被认为是十字迷宫中运动活动的有效指标。这些结果支持dPAG是涉及OTT现象神经生物学的关键结构,并说明了位于该中脑结构内的5-HT(2A)和5-HT(2C)受体在EPM测试和重新测试范式小鼠诱导的情绪状态中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验